Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
NOVEL INSULIN
Not Marketed
Diabetes Mellitus, Type 1
TDU10987NANCT01053728Summary
OLIPUDASE ALFA
Xenpozyme®
Sphingomyelin lipidosis
LTS13632NANCT02004704Summary
OLIPUDASE ALFA
Xenpozyme®
Acid Sphingomyelinase Deficiency
DFI12712ASCENDNCT02004691Tabulated resultsSummary
OLIPUDASE ALFA
Not marketed
Sphingomyelin Lipidosis
DFI13803ASCEND-PedsEudraCT: 2014-003198-40Tabulated Results
OMBRABULIN
Not marketed
Advanced sarcoma
EFC10145NAEudraCT: 2007-003592-39Summary Results
OMBRABULIN
Not marketed
Non-small cell lung cancer
EFC10259DISRUPTEudraCT: 2010-019384-11Summary Results
OMBRABULIN
Not marketed
Ovarian cancer recurrent
EFC10260OPSALINNCT01332656Summary
OMBRABULIN
Not marketed
Advanced solid tumors
TCD11270NANCT01293630Summary
OMBRABULIN
Not marketed
Advanced solid tumors
TCD11379NANCT01193595Summary
OTAMIXABAN
Not marketed
Acute Coronary Syndrome
DRI6624SEPIA-(ACS1)NCT00317395Publication's reference

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted